跳至主要内容
临床试验/NCT03204149
NCT03204149终止不适用

Evaluation of Safety of Low Level Laser MC-8XL Device Treatment in Chronic Wounds

Medical Coherence LLC1 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2017年6月14日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
5
试验地点
1
主要终点
Safety

研究概览

简要总结

This is a randomized, double blind, placebo-controlled study to evaluate the safety of the low level laser MC-8XL device treatment in subjects with an unsuccessfully treated Diabetic Foot Ulcer (DFU) that has been present for at least 3 months.

Eligible subjects will be randomized to either Treatment group or Control group, following which, treatment of each subject will be provided by a qualified nurse at the clinic or in the home setting, everyday for up to 16 weeks.

Study assessments and adverse events monitoring will be also performed throughout the study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Provide signed and dated Informed Consent Form
  • •Willing to comply with all study procedures and be available for the duration of the study
  • •Male or female, aged 18 to 90
  • •Having a DFU of at least 3 months duration that had not improved after prior standard wound treatments
  • •HbA1c of <11.0
  • •Size of wounds: 1-10 cm2
  • •Having DFU of grades 2 or 3 according to Wagner's classification

排除标准

  • •Immeasurable wounds or wounds that are unsuited to this laser treatment (usually due to the wound's location, e.g. in the area between the toes).
  • •Uncontrolled Diabetes defined as an HbA1c of > 11.0
  • •Arterial insufficiency, Doppler vascular assessment (if needed- Ankle Brachial Index (ABI) < 0.6)
  • •Osteomyelitis in the bone.
  • •Photosensitivity
  • •Pregnancy
  • •Presence of any suspicious pre-cancerous or cancerous lesions, or having cancer.
  • •Being on medications that are immunosuppressive, may affect peripheral blood flow or may affect normal wound healing.
  • •Being on medications that might cause photosensitivity.
  • •Participation in any other clinical trial testing a device or drug.

研究组 & 干预措施

Treatment group

Experimental

The treatment group will be treated with the MC-8XL laser device, emitting 808 nm laser beam with a green laser beam.

Intervention: MC-8XL low level laser device and Standard wound care

干预措施: MC-8XL low level laser device and Standard wound care (Device)

Control group

Sham Comparator

The control group will receive treatment with a sham laser device, emitting a low power green light with inactive Infrared (IR) laser for indication only.

Intervention: Sham laser device and Standard wound care

干预措施: Sham laser device and Standard wound care (Device)

结局指标

主要结局

Safety

时间窗: On a weekly basis until the end of the 16 week treatment period

assessing device related and general adverse events

次要结局

  • Wound Healing(On a weekly basis until the end of the 16 week treatment period or until complete wound closure)

研究者

发起方
Medical Coherence LLC
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验